Cargando…

How Should We Measure and Deal with Office Blood Pressure in 2021?

Arterial hypertension is a major risk factor for cardiovascular disease worldwide. Office blood pressure measurements (OBPMs) are still recommended for diagnosis and follow-up by all major guidelines; however, the recommended procedures differ significantly. In analogy, major outcome studies usually...

Descripción completa

Detalles Bibliográficos
Autores principales: Vischer, Annina S., Burkard, Thilo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7913758/
https://www.ncbi.nlm.nih.gov/pubmed/33546474
http://dx.doi.org/10.3390/diagnostics11020235
_version_ 1783656876316033024
author Vischer, Annina S.
Burkard, Thilo
author_facet Vischer, Annina S.
Burkard, Thilo
author_sort Vischer, Annina S.
collection PubMed
description Arterial hypertension is a major risk factor for cardiovascular disease worldwide. Office blood pressure measurements (OBPMs) are still recommended for diagnosis and follow-up by all major guidelines; however, the recommended procedures differ significantly. In analogy, major outcome studies usually apply OBPMs, again, with a variety of procedures. This variety of OBPM procedures complicates the comparability between studies and challenges daily clinical practice. In this narrative review, we compile the most recent recommendations for office blood pressure measurement together with the major limitations and strategies and how these could be overcome.
format Online
Article
Text
id pubmed-7913758
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-79137582021-02-28 How Should We Measure and Deal with Office Blood Pressure in 2021? Vischer, Annina S. Burkard, Thilo Diagnostics (Basel) Review Arterial hypertension is a major risk factor for cardiovascular disease worldwide. Office blood pressure measurements (OBPMs) are still recommended for diagnosis and follow-up by all major guidelines; however, the recommended procedures differ significantly. In analogy, major outcome studies usually apply OBPMs, again, with a variety of procedures. This variety of OBPM procedures complicates the comparability between studies and challenges daily clinical practice. In this narrative review, we compile the most recent recommendations for office blood pressure measurement together with the major limitations and strategies and how these could be overcome. MDPI 2021-02-03 /pmc/articles/PMC7913758/ /pubmed/33546474 http://dx.doi.org/10.3390/diagnostics11020235 Text en © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Vischer, Annina S.
Burkard, Thilo
How Should We Measure and Deal with Office Blood Pressure in 2021?
title How Should We Measure and Deal with Office Blood Pressure in 2021?
title_full How Should We Measure and Deal with Office Blood Pressure in 2021?
title_fullStr How Should We Measure and Deal with Office Blood Pressure in 2021?
title_full_unstemmed How Should We Measure and Deal with Office Blood Pressure in 2021?
title_short How Should We Measure and Deal with Office Blood Pressure in 2021?
title_sort how should we measure and deal with office blood pressure in 2021?
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7913758/
https://www.ncbi.nlm.nih.gov/pubmed/33546474
http://dx.doi.org/10.3390/diagnostics11020235
work_keys_str_mv AT vischeranninas howshouldwemeasureanddealwithofficebloodpressurein2021
AT burkardthilo howshouldwemeasureanddealwithofficebloodpressurein2021